Cargando…

Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis

BACKGROUND: The association between lipoprotein-associated phospholipase A2 (Lp-PLA2) and stroke risk is inconsistent. We conducted a meta-analysis to determine whether elevated Lp-PLA2 is a risk factor for stroke. METHODS: Studies were included if they reported Lp-PLA2 mass and/or activity levels a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Gaifeng, Liu, Deping, Tong, Huiyu, Huang, Weijun, Hu, Yunzhao, Huang, Yuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545803/ https://www.ncbi.nlm.nih.gov/pubmed/31236414 http://dx.doi.org/10.1155/2019/8642784

Ejemplares similares

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Plasma Oxidized Low-Density Lipoprotein Is an Independent Risk Factor in Young Patients with Coronary Artery Disease
por: Huang, Yuli, et al.
Publicado: (2011)

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A(2) in Ischemic Stroke
por: Zhang, Shuang, et al.
Publicado: (2022)

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Chen, Ying, et al.
Publicado: (2015)

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality
por: Huang, Yuli, et al.
Publicado: (2017)

Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant
por: Huang, Weijun, et al.
Publicado: (2023)

Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
por: Huang, Yuli, et al.
Publicado: (2016)

Evolutionary de Winter pattern: from STEMI to de Winter ECG—a case report
por: Huang, Weijun, et al.
Publicado: (2021)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis
por: Xu, Tianyu, et al.
Publicado: (2015)

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
por: Wu, Zubo, et al.
Publicado: (2021)

Prehypertension and the Risk of Coronary Heart Disease in Asian and Western Populations: A Meta‐analysis
por: Huang, Yuli, et al.
Publicado: (2015)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
por: Xu, Tianyu, et al.
Publicado: (2019)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
Publicado: (2010)

Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
por: Zhang, Xiaojiu, et al.
Publicado: (2022)

Prehypertension and incidence of cardiovascular disease: a meta-analysis
por: Huang, Yuli, et al.
Publicado: (2013)

Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
por: Cai, Xiaoyan, et al.
Publicado: (2020)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Prevalence and risk factors associated with prehypertension in Shunde District, southern China
por: Huang, Yuli, et al.
Publicado: (2014)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Age- and Sex-Specific Association between Lipoprotein-Related Phospholipase A2 and Cardiometabolic Risk Factors
por: Ke, Pin-Hsuan, et al.
Publicado: (2023)

The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A(2): A systematic review and meta-analysis
por: Tian, Ye, et al.
Publicado: (2017)

High-sensitivity C-reactive protein, lipoprotein-related phospholipase A(2), and acute ischemic stroke
por: Kara, Hasan, et al.
Publicado: (2014)

Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis
por: Nejati, Majid, et al.
Publicado: (2018)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients
por: Huang, Yuli, et al.
Publicado: (2017)

Lipoprotein-Associated Phospholipase A(2) Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus
por: Fortunato, J., et al.
Publicado: (2014)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension
por: Li, Zhiming, et al.
Publicado: (2016)

Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes
por: Cai, Rongrong, et al.
Publicado: (2017)

Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis
por: Cao, Jing, et al.
Publicado: (2021)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment
por: Zhu, Shuzhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dr21827rbudvv9hrht5tlr3aec